Azitra (AZTR) Other financing activities (2022 - 2023)
Azitra (AZTR) reported Other financing activities of $272080.0 for Q1 2023, up 54.43% quarter-over-quarter from $176183.0 in Q4 2022.
Azitra (AZTR) Other financing activities (2022 - 2023) Analysis & Trends
Azitra has reported Other financing activities for 2 years, with the latest figure at $272080.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 272,080.00 |
| Mar 31, 2023 | 272,080.00 |
| Dec 31, 2022 | 176,183.00 |
| Dec 31, 2022 | 176,183.00 |